COMMUNIQUÉS West-GlobeNewswire
-
ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury
09/09/2026 -
Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial
09/09/2026 -
Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide
09/09/2026 -
Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers
09/09/2026 -
Athernal Bio Secures Innovate UK Grant to Advance Cancer Interception in High-Risk Leukaemia
09/09/2026 -
Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes
09/09/2026 -
RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026
09/09/2026 -
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
09/09/2026 -
ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline
09/09/2026 -
GENFIT présente le potentiel commercial à long terme de sa technologie de diagnostic dans la MASH
09/09/2026 -
GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology
09/09/2026 -
Pharming Group to participate in September investor conferences
09/09/2026 -
Allegro’s Hydrocelin significantly improves knee osteoarthritis pain and function in clinical trial
09/09/2026 -
ICG-21 Opens in Shenzhen, Spotlighting Bio-Generative Intelligence for Health and New Frontiers in Genomics
09/09/2026 -
InnoCare Announces Approval of Clinical Trial of Novel Bispecific ADC ICP-B381 Targeting PSMA/ STEAP1 in China
09/09/2026 -
XORTX Re-Engages Investor Relations Program
09/09/2026 -
HealthEx Empowers Consumers to Bring Their Personal Health History to Muse, Meta’s New Personal AI Agent
08/09/2026 -
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
08/09/2026 -
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer
08/09/2026
Pages